Evolving liver disease insights from NAFLD to MASLD

Trends in Endocrinology & Metabolism Pub Date : 2024-02-29 DOI:10.1016/j.tem.2024.02.012

Xiude Fan, Yongfeng Song, Jiajun Zhao

引用次数: 0

Abstract

The recent renaming of ‘non-alcoholic fatty liver disease’ (NAFLD) to ‘metabolic dysfunction-associated steatotic liver disease’ (MASLD) emphasizes metabolic dysfunction in steatotic liver disease and advocates for tailored, comprehensive treatment strategies, driving forward the development of personalized care and innovative therapeutic approaches.

查看原文本刊更多论文

从 NAFLD 到 MASLD 不断发展的肝脏疾病见解

最近，"非酒精性脂肪肝"（NAFLD）更名为 "代谢功能障碍相关性脂肪性肝病"（MASLD），强调了脂肪性肝病中的代谢功能障碍，倡导量身定制的综合治疗策略，推动个性化护理和创新治疗方法的发展。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Trends in Endocrinology & Metabolism

自引率

0.00%

发文量